Fennec Pharmaceuticals has presented real world data supporting the integration [...]

Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]

Abivax has presented new preclinical and clinical data for obefazimod [...]

Aspargo Labs, Inc., a pharmaceutical company commercializing a highly absorbent [...]

Long-term VIVID-2 data show more than 90% of patients with [...]

Affibody has reported positive Phase 1 data from its licensee [...]

Sensei Biotherapeutics has acquired Faeth Therapeutics and announced a concurrent [...]

Axplora is investing several million euros to expand lyophilisation capacity [...]

Polaryx Therapeutics, Inc has selected a leading contract research organization [...]

GSK announced that the European Commission has approved Exdensur (depemokimab) [...]